802 related articles for article (PubMed ID: 24484256)
1. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
[TBL] [Abstract][Full Text] [Related]
2. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
3. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
[TBL] [Abstract][Full Text] [Related]
5. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
[TBL] [Abstract][Full Text] [Related]
6. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
[TBL] [Abstract][Full Text] [Related]
8. Histopathological Insights on Imaging Results of Intraoperative Magnetic Resonance Imaging, 5-Aminolevulinic Acid, and Intraoperative Ultrasound in Glioblastoma Surgery.
Coburger J; Scheuerle A; Pala A; Thal D; Wirtz CR; König R
Neurosurgery; 2017 Jul; 81(1):165-174. PubMed ID: 28204539
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and specificity of linear array intraoperative ultrasound in glioblastoma surgery: a comparative study with high field intraoperative MRI and conventional sector array ultrasound.
Coburger J; Scheuerle A; Kapapa T; Engelke J; Thal DR; Wirtz CR; König R
Neurosurg Rev; 2015 Jul; 38(3):499-509; discussion 509. PubMed ID: 25855197
[TBL] [Abstract][Full Text] [Related]
10. Combination of Intraoperative Magnetic Resonance Imaging and Intraoperative Fluorescence to Enhance the Resection of Contrast Enhancing Gliomas.
Gessler F; Forster MT; Duetzmann S; Mittelbronn M; Hattingen E; Franz K; Seifert V; Senft C
Neurosurgery; 2015 Jul; 77(1):16-22; discussion 22. PubMed ID: 25812066
[TBL] [Abstract][Full Text] [Related]
11. Linear array ultrasound in low-grade glioma surgery: histology-based assessment of accuracy in comparison to conventional intraoperative ultrasound and intraoperative MRI.
Coburger J; Scheuerle A; Thal DR; Engelke J; Hlavac M; Wirtz CR; König R
Acta Neurochir (Wien); 2015 Feb; 157(2):195-206. PubMed ID: 25559430
[TBL] [Abstract][Full Text] [Related]
12. Role of neurochemical navigation with 5-aminolevulinic acid during intraoperative MRI-guided resection of intracranial malignant gliomas.
Yamada S; Muragaki Y; Maruyama T; Komori T; Okada Y
Clin Neurol Neurosurg; 2015 Mar; 130():134-9. PubMed ID: 25615582
[TBL] [Abstract][Full Text] [Related]
13. Combined Use of 5-Aminolevulinic Acid and Intraoperative Low-Field Magnetic Resonance Imaging in High-Grade Glioma Surgery.
Bassaganyas-Vancells C; Roldán P; González JJ; Ferrés A; García S; Culebras D; Hoyos J; Reyes L; Torales J; Enseñat J
World Neurosurg; 2019 Oct; 130():e206-e212. PubMed ID: 31203073
[TBL] [Abstract][Full Text] [Related]
14. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgery.
Schatlo B; Fandino J; Smoll NR; Wetzel O; Remonda L; Marbacher S; Perrig W; Landolt H; Fathi AR
Neuro Oncol; 2015 Dec; 17(12):1560-7. PubMed ID: 25858636
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
Coburger J; Wirtz CR
J Neurooncol; 2019 Feb; 141(3):533-546. PubMed ID: 30488293
[TBL] [Abstract][Full Text] [Related]
17. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.
Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J
Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248
[TBL] [Abstract][Full Text] [Related]
18. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
19. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
[TBL] [Abstract][Full Text] [Related]
20. Factors triggering an additional resection and determining residual tumor volume on intraoperative MRI: analysis from a prospective single-center registry of supratentorial gliomas.
Scherer M; Jungk C; Younsi A; Kickingereder P; Müller S; Unterberg A
Neurosurg Focus; 2016 Mar; 40(3):E4. PubMed ID: 26926062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
